APA

Janku F., Hong D. S., Fu S., Piha-Paul S. A., Naing A., Falchook G. S., Tsimberidou A. M., Stepanek V. M., Moulder S. L., Lee J. J., Luthra R., Zinner R. G., Broaddus R. R., Wheler J. J. & Kurzrock R. (20140926). Assessing PIK3CA and PTEN in early-phase trials with PI3K/AKT/mTOR inhibitors. : Cell reports.

Chicago

Janku Filip, Hong David S, Fu Siqing, Piha-Paul Sarina A, Naing Aung, Falchook Gerald S, Tsimberidou Apostolia M, Stepanek Vanda M, Moulder Stacy L, Lee J Jack, Luthra Rajyalakshmi, Zinner Ralph G, Broaddus Russell R, Wheler Jennifer J and Kurzrock Razelle. 20140926. Assessing PIK3CA and PTEN in early-phase trials with PI3K/AKT/mTOR inhibitors. : Cell reports.

Harvard

Janku F., Hong D. S., Fu S., Piha-Paul S. A., Naing A., Falchook G. S., Tsimberidou A. M., Stepanek V. M., Moulder S. L., Lee J. J., Luthra R., Zinner R. G., Broaddus R. R., Wheler J. J. and Kurzrock R. (20140926). Assessing PIK3CA and PTEN in early-phase trials with PI3K/AKT/mTOR inhibitors. : Cell reports.

MLA

Janku Filip, Hong David S, Fu Siqing, Piha-Paul Sarina A, Naing Aung, Falchook Gerald S, Tsimberidou Apostolia M, Stepanek Vanda M, Moulder Stacy L, Lee J Jack, Luthra Rajyalakshmi, Zinner Ralph G, Broaddus Russell R, Wheler Jennifer J and Kurzrock Razelle. Assessing PIK3CA and PTEN in early-phase trials with PI3K/AKT/mTOR inhibitors. : Cell reports. 20140926.